150 related articles for article (PubMed ID: 33371988)
1. Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN).
Carton L; Nourredine M; Rolland B
Therapie; 2021; 76(2):127-136. PubMed ID: 33371988
[TBL] [Abstract][Full Text] [Related]
2. Neuroscience-Based Nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs.
Galduroz JCF; Zampronio AR; Vital MABF; Sallet PC; Zohar J; Andreatini R
Trends Psychiatry Psychother; 2024 Jan; ():. PubMed ID: 38240314
[TBL] [Abstract][Full Text] [Related]
3. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.
Zohar J; Stahl S; Moller HJ; Blier P; Kupfer D; Yamawaki S; Uchida H; Spedding M; Goodwin GM; Nutt D
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2318-25. PubMed ID: 26527055
[TBL] [Abstract][Full Text] [Related]
4. Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.
Karoly HC; YorkWilliams SL; Hutchison KE
Alcohol Clin Exp Res; 2015 Nov; 39(11):2073-84. PubMed ID: 26414497
[TBL] [Abstract][Full Text] [Related]
5. Neuroscience-Based Nomenclature for Psychotropic Medication.
Hutson E; Ellington E; Hardy L
J Psychosoc Nurs Ment Health Serv; 2023 Jul; 61(7):9-13. PubMed ID: 37389943
[TBL] [Abstract][Full Text] [Related]
6. The Neuroscience-based Nomenclature Child & Adolescent (NbN C&A) for Psychotropic Medications: Innovation in Progress.
Cortese S; Singh MK; Novins DK
J Am Acad Child Adolesc Psychiatry; 2022 Nov; 61(11):1317-1318. PubMed ID: 35697264
[TBL] [Abstract][Full Text] [Related]
7. A new nomenclature for classifying psychotropic drugs.
Caraci F; Enna SJ; Zohar J; Racagni G; Zalsman G; van den Brink W; Kasper S; Koob GF; Pariante CM; Piazza PV; Yamada K; Spedding M; Drago F
Br J Clin Pharmacol; 2017 Aug; 83(8):1614-1616. PubMed ID: 28401576
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.
Lin SK
Br J Clin Pharmacol; 2014 Feb; 77(2):242-52. PubMed ID: 23701272
[TBL] [Abstract][Full Text] [Related]
9. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature.
Tang SW; Tang WH; Leonard BE
World J Biol Psychiatry; 2019 Oct; 20(8):586-604. PubMed ID: 28649903
[No Abstract] [Full Text] [Related]
10. Future pharmacological treatments for substance use disorders.
Forray A; Sofuoglu M
Br J Clin Pharmacol; 2014 Feb; 77(2):382-400. PubMed ID: 23039267
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of dual substance abuse and dependence.
Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
[TBL] [Abstract][Full Text] [Related]
12. [Newly developed nomenclature (Neuroscience-based Nomenclature)].
Uchida H; Yamawaki S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Jun; 36(3):69-71. PubMed ID: 27506083
[TBL] [Abstract][Full Text] [Related]
13. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
Park TW; Friedmann PD
R I Med J (2013); 2014 Oct; 97(10):20-4. PubMed ID: 25271655
[TBL] [Abstract][Full Text] [Related]
14. Neuroscience-based nomenclature as a teaching tool, introduction and pilot study.
Zemach S; Minkin Levy D; Zohar J
Int Clin Psychopharmacol; 2023 Sep; 38(5):329-335. PubMed ID: 37159166
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of addictive disorders.
Ross S; Peselow E
Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993
[TBL] [Abstract][Full Text] [Related]
16. Medications development for food-based and drug use disorders.
de Moura FB; Kohut SJ; Bergman J
Adv Pharmacol; 2019; 86():197-236. PubMed ID: 31378252
[TBL] [Abstract][Full Text] [Related]
17. IUPHAR Review: New strategies for medications to treat substance use disorders.
Montoya ID; Volkow ND
Pharmacol Res; 2024 Feb; 200():107078. PubMed ID: 38246477
[TBL] [Abstract][Full Text] [Related]
18. What Is Addiction? History, Terminology, and Core Concepts.
Olsen Y
Med Clin North Am; 2022 Jan; 106(1):1-12. PubMed ID: 34823724
[TBL] [Abstract][Full Text] [Related]
19. Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
O'Brien CP
Am J Psychiatry; 2005 Aug; 162(8):1423-31. PubMed ID: 16055763
[TBL] [Abstract][Full Text] [Related]
20. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?
Ward J; Rosenbaum C; Hernon C; McCurdy CR; Boyer EW
CNS Drugs; 2011 Dec; 25(12):999-1007. PubMed ID: 22133323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
